Can you interpret the abdominal ultrasound findings of a 70‑year‑old patient for me as a primary care physician?

Interpretation of Abdominal Ultrasound Findings

This ultrasound shows fatty liver disease with concerning but likely falsely elevated elastography suggesting cirrhosis (F4 fibrosis), which contradicts the grayscale imaging showing no cirrhotic features—the grayscale findings should take precedence given the technical limitations explicitly noted in the report.

Key Clinical Findings and Their Significance

Hepatic Steatosis (Fatty Liver)

The liver appears fatty on grayscale imaging but not cirrhotic. This is the most important finding to focus on. 1 recommend that patients with fatty liver disease, especially those over 70 with likely metabolic risk factors, should be screened for:

• Diabetes mellitus (if not already diagnosed)
• Metabolic syndrome components (hypertension, dyslipidemia, obesity)
• Chronic kidney disease (which frequently coexists with NAFLD)

The report notes the liver measures 16.4 cm, which is within normal limits (<17 cm).

The Elastography Discrepancy—Critical Interpretation Point

The report itself states the elastography values are "extremely elevated with a wide variety of range, suggesting these are inaccurate" with a METAVIR score of F4 (cirrhosis). However, the radiologist appropriately notes these values are "falsely elevated due to steatosis, poor penetration of the body habitus, overlying bowel gas, or other technical factors."

You should not diagnose cirrhosis based on this study. 1 The grayscale imaging shows no cirrhotic features, and the technical limitations are explicitly acknowledged. Steatosis itself is known to falsely elevate elastography measurements 1.

What You Should Do Next

For the fatty liver finding:

1. Exclude secondary causes of hepatic steatosis 2:

   • Hepatitis B and C serology
   • Alcohol use assessment (detailed history)
   • Medication review (many drugs cause steatosis)
   • Check for metabolic syndrome components

2. Assess for advanced fibrosis risk using non-invasive panels 1:

   • FIB-4 score (age, AST, ALT, platelet count)—most practical for primary care
   • NAFLD Fibrosis Score if metabolic syndrome present
   • These are more reliable than the flawed elastography in this case

3. If FIB-4 or clinical suspicion suggests significant fibrosis, refer to hepatology for:

   • Proper elastography (FibroScan/transient elastography) under optimal conditions
   • Or consider MR elastography, which has better accuracy 1

For the renal cyst: The 2.7 cm septated left renal cyst typically requires no follow-up per the radiologist's assessment. This is appropriate for a simple or minimally complex cyst in a 70-year-old.

Common Pitfalls to Avoid

1. Do not label this patient as cirrhotic based on the F4 elastography score—the report explicitly warns against this interpretation
2. Do not ignore the fatty liver just because there's no cirrhosis—NAFLD itself increases risk for cardiovascular disease, diabetes, and CKD 1
3. Do not assume normal ALT means no significant liver disease—up to 30% of NAFLD patients have normal aminotransferases 2

Screening Recommendations Going Forward

For a 70-year-old with fatty liver 1, 3:

• Screen for hepatocellular carcinoma if any evidence of advanced fibrosis develops (ultrasound every 6 months)
• Cardiovascular risk assessment (NAFLD significantly increases CV mortality)
• Lifestyle modification counseling (weight loss of 7-10% improves steatosis and fibrosis)

Bottom Line for Clinical Management

Treat this as non-cirrhotic fatty liver disease with uncertain fibrosis stage. Calculate a FIB-4 score with available labs. If FIB-4 is <1.3, advanced fibrosis is unlikely and routine monitoring is appropriate. If FIB-4 is >2.67 (or 1.3-2.67 in the indeterminate zone), refer to hepatology for proper fibrosis assessment with validated techniques under optimal conditions 1. Address metabolic risk factors aggressively regardless of fibrosis stage.